Jade Biosciences/$JBIO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Jade Biosciences
Jade Biosciences Inc is focused on developing therapies to address critical unmet needs in autoimmune diseases. Its asset, JADE-001, will target the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for immunoglobulin A (IgA) nephropathy, with Investigational New Drug Application-enabling studies underway and initiation of a first-in-human trial. Jade's pipeline also includes two undisclosed optimized antibody discovery programs, JADE-002 and JADE-003, currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount.
Ticker
$JBIO
Sector
Health
Primary listing
Employees
30
Headquarters
Website
Jade Biosciences Metrics
BasicAdvanced
$236M
-
-$18.79
-
$84.00
1,147.54%
Price and volume
Market cap
$236M
52-week high
$13.47
52-week low
$6.57
Average daily volume
312K
Dividend rate
$84.00
Financial strength
Current ratio
5.806
Quick ratio
5.784
Long term debt to equity
-229.929
Total debt to equity
-229.929
Profitability
Management effectiveness
Valuation
Price to book
-0.91
Price to tangible book (TTM)
-0.91
Price to free cash flow (TTM)
-0.809
Free cash flow yield (TTM)
-123.57%
Free cash flow per share (TTM)
-9.046
Dividend yield (TTM)
1,147.54%
Growth
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Jade Biosciences stock?
Jade Biosciences (JBIO) has a market cap of $236M as of August 09, 2025.
What is the P/E ratio for Jade Biosciences stock?
The price to earnings (P/E) ratio for Jade Biosciences (JBIO) stock is 0 as of August 09, 2025.
Does Jade Biosciences stock pay dividends?
Yes, the Jade Biosciences (JBIO) stock pays dividends to shareholders. As of August 09, 2025, the dividend rate is $84 and the yield is 1147.54%. Jade Biosciences has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Jade Biosciences dividend payment date?
The next Jade Biosciences (JBIO) dividend payment date is unconfirmed.
What is the beta indicator for Jade Biosciences?
Jade Biosciences (JBIO) does not currently have a Beta indicator.